MedPage Today on MSN
Understanding Osteoporosis in Older Men
These include the RANKL inhibitor denosumab (Prolia), the anabolic agents teriparatide (Forteo) and abaloparatide (Tymlos), ...
The approval was based on a comprehensive clinical data package that included a phase 3 trial comparing denosumab-qbde with Prolia in 473 women with postmenopausal osteoporosis.
MedPage Today on MSN
Preventing Osteoporosis With Drug Therapy
Beyond antiresorptive medications, anabolic bone-building medications, including teriparatide, abaloparatide (Tymlos), and ...
BENGALURU, India and BRIDGEWATER, N.J., Sept. 17, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of ...
Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback